Alzheimer's research & therapy
Published

Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer's disease

Authors

Valentina Di Caro, Eunah Cho, Jill Thiel, Britney N Lizama, Marleen J A Koel-Simmelink, Kiran Pandey, Duc Duong, Nicholas T Seyfried, Michael Grundman, Charlotte E Teunissen, Henrik Zetterberg, Kaj Blennow, Anthony O Caggiano, Mary E Hamby
Read More

Abstract

Alzheimers Res Ther. 2026 Apr 6. doi: 10.1186/s13195-026-02025-4. Online ahead of print.

NO ABSTRACT

PMID:41943055 | DOI:10.1186/s13195-026-02025-4

UK DRI Authors

Profile picture of Henrik Zetterberg

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Prof Henrik Zetterberg